StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Acro Biomedical's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0. The highest annual figure on record is $8.01M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$658.50K-45.0%
FY2021Dec 31, 2021$1.20M-11.6%
FY2019Sep 30, 2019$1.35M-83.1%
FY2018Sep 30, 2018$8.01M+1471.5%
FY2017Sep 30, 2017$510.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$0–
Q1 FY2026CQ1 2026Mar 31, 2026$0–
Q4 FY2025CQ4 2025Dec 31, 2025$0–
Q3 FY2025CQ3 2025Sep 30, 2025$0–
Q2 FY2025CQ2 2025Jun 30, 2025$0–
Q1 FY2025CQ1 2025Mar 31, 2025$0–
Q4 FY2024CQ4 2024Dec 31, 2024$0–
Q3 FY2024CQ3 2024Sep 30, 2024$0–
Q2 FY2024CQ2 2024Jun 30, 2024$0–
Q1 FY2024CQ1 2024Mar 31, 2024$0–
Q4 FY2023CQ4 2023Dec 31, 2023$0-100.0%
Q3 FY2023CQ3 2023Sep 30, 2023$0–
Q2 FY2023CQ2 2023Jun 30, 2023$0–
Q1 FY2023CQ1 2023Mar 31, 2023$0-100.0%
Q4 FY2022CQ4 2022Dec 31, 2022$360.00K-39.8%
Q3 FY2022CQ3 2022Sep 30, 2022$0–
Q2 FY2022CQ2 2022Jun 30, 2022$0-100.0%
Q1 FY2022CQ1 2022Mar 31, 2022$298.50K+200.0%
Q4 FY2021CQ4 2021Dec 31, 2021$598.00K–
Q3 FY2021CQ3 2021Sep 30, 2021$0–
Q2 FY2021CQ2 2021Jun 30, 2021$500.00K–
Q1 FY2021CQ1 2021Mar 31, 2021$99.50K-92.7%
Q4 FY2019CQ3 2019Sep 30, 2019$0-100.0%
Q3 FY2019CQ2 2019Jun 30, 2019$0-100.0%
Q2 FY2019CQ1 2019Mar 31, 2019$0-100.0%
Q1 FY2019CQ4 2018Dec 31, 2018$1.35M-6.3%
Q4 FY2018CQ3 2018Sep 30, 2018$2.41M–
Q3 FY2018CQ2 2018Jun 30, 2018$2.20M–
Q2 FY2018CQ1 2018Mar 31, 2018$1.96M–
Q1 FY2018CQ4 2017Dec 31, 2017$1.45M–

More Acro Biomedical figures

See a number that looks wrong?